A systematic evaluation of multi-gene predictors for the pathological response of breast cancer patients to chemotherapy.

A systematic evaluation of multi-gene predictors for the pathological response of breast cancer patients to chemotherapy.

Previous studies have reported conflicting assessments of the ability of cell line-derived multi-gene predictors (MGPs) to forecast patient clinical outcomes in cancer patients, thereby warranting an investigation into their suitability for this task. Here, 42 breast cancer cell lines were evaluated...

Full description

Bibliographic Details
Main Authors:	Kui Shen, Nan Song, Youngchul Kim, Chunqiao Tian, Shara D Rice, Michael J Gabrin, W Fraser Symmans, Lajos Pusztai, Jae K Lee
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3504014?pdf=render

Similar Items

Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial
by: Shen Kui, et al.
Published: (2012-11-01)

Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response
by: Pusztai Lajos, et al.
Published: (2011-07-01)

Distinct genes related to drug response identified in ER positive and ER negative breast cancer cell lines.
by: Kui Shen, et al.
Published: (2012-01-01)

Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis.
by: Tingting Jiang, et al.
Published: (2016-12-01)

Regulation of the growth of human breast cancer by tumour necrosis factor-alpha
by: Pusztai, Lajos
Published: (1993)

The Bimodality Index: A criterion for Discovering and Ranking Bimodal Signatures from Cancer Gene Expression Profiling Data
by: Jing Wang, et al.
Published: (2009-01-01)

The Bimodality Index: A Criterion for Discovering and Ranking Bimodal Signatures from Cancer Gene Expression Profiling Data
by: Jing Wang, et al.
Published: (2009-01-01)

Lack of sufficiently strong informative features limits the potential of gene expression analysis as predictive tool for many clinical classification problems
by: Hess Kenneth R, et al.
Published: (2011-12-01)

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
by: Wilson Eduardo Furlan Matos Alves, et al.
Published: (2019-12-01)

The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients
by: Sunao Tanaka, et al.
Published: (2017-04-01)

Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review
by: Xu W, et al.
Published: (2020-06-01)

Predictors of hope among women with breast cancer during chemotherapy
by: Alessandra Cristina Sartore Balsanelli, et al.

Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer
by: Zhao Y, et al.
Published: (2015-06-01)

A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma
by: Kunnuru SKR, et al.
Published: (2020-11-01)

Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
by: J Stuart Ferriss, et al.
Published: (2012-01-01)

Epithelial-Mesenchymal Transition Markers in Breast Cancer and Pathological Responseafter Neoadjuvant Chemotherapy
by: Shaimaa Elzamly, et al.
Published: (2018-01-01)

Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer
by: Anne-Sophie Hamy, et al.
Published: (2020-01-01)

Predicting pathological complete response in the axilla post neoadjuvant chemotherapy in carcinoma breast
by: A. AbduRahman, et al.
Published: (2021-04-01)

Long-term Outcomes and Predictors for response of Breast Cancer following Neoadjuvant Chemotherapy
by: Dong-Hua Wang, et al.
Published: (2019)

Predictors of symptom distress in women with breast cancer during the first chemotherapy cycle
by: Marcia M. Boehmke, et al.
Published: (2005-10-01)

Prediction of the outcome of preoperative chemotherapy in breast cancer using DNA probes that provide information on both complete and incomplete responses
by: Coutant Charles, et al.
Published: (2008-03-01)

Immune factors associated with the pathological and therapeutic effects of preoperative chemotherapy in patients with breast cancer
by: Ryungsa Kim, et al.
Published: (2021-01-01)

Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response
by: Uanderson Resende, et al.
Published: (2019-06-01)

Assessment of pathological response to neoadjuvant chemotherapy in patients with breast carcinoma using Sataloff system
by: Savita Agarwal, et al.
Published: (2019-01-01)

Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer
by: Sunghoon Joo, et al.
Published: (2021-09-01)

Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
by: Gonzalez-Angulo Ana M, et al.
Published: (2011-07-01)

The Role of 18F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis
by: Qiufang Liu, et al.
Published: (2016-01-01)

Evaluation of Clinical and Pathological Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer and Correlation with Biological Factors and Type of Chemotherapy
by: Seyed Hadi Chavoshi, et al.
Published: (2018-09-01)

The modern views of the clinical, morphological and molecular biological predictors of breast cancer sensitivity to chemotherapy
by: E. Yu. Zubareva, et al.
Published: (2020-09-01)

Reproducibility of Variant Calls in Replicate Next Generation Sequencing Experiments.
by: Yuan Qi, et al.
Published: (2015-01-01)

Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients
by: Chao You, et al.
Published: (2017-10-01)

Corrigendum to “The Role of 18F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis”
by: Qiufang Liu, et al.
Published: (2016-01-01)

Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance
by: Vasiliki Pelekanou, et al.
Published: (2017-08-01)

The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study
by: Xu Chaoyang, et al.
Published: (2009-07-01)

Some properties of filtered pseudorandom sequences
by: Gabrin, P.
Published: (1974)

Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast Cancer
by: Taher Al-Tweigeri, et al.
Published: (2021-01-01)

Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer
by: O A Pavlikova, et al.
Published: (2017-01-01)

Assessment of Pathological Response of Breast Carcinoma in Modified Radical Mastectomy Specimens after Neoadjuvant Chemotherapy
by: Dhanya Vasudevan, et al.
Published: (2015-01-01)

Role of postmastectomy radiation therapy in breast cancer patients with different pathological responses to neoadjuvant chemotherapy
by: Huan Guo, et al.
Published: (2017-12-01)

Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple negative breast cancer (TNBC)
by: P. Krivorotko, et al.
Published: (2021-04-01)